Research programme: toll-like receptor 8 agonists and antagonists - VentiRxAlternative Names: VTX-294; VTX-378; VTX-763
Latest Information Update: 15 Feb 2017
At a glance
- Originator Array BioPharma
- Developer VentiRx Pharmaceuticals
- Class Benzazepines; Small molecules
- Mechanism of Action Toll-like receptor 8 agonists; Toll-like receptor 8 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders
- No development reported Cancer; Hypersensitivity